Skip to main content
Log in

ASO Visual Abstract: Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Funding

This work was supported by NIH grants (Grant Nos. U01210170 and R01CA176828 CA62924), Susan Wojcicki and Dennis Troper, a Stand Up to Cancer-Lustgarten Foundation Pancreatic Cancer Interception Translational Cancer Research grant (Grant No. SU2C-AACR-DT25-17). Stand Up to Cancer is a program of the Entertainment Industry Foundation. The SU2C research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Goggins MB, MD.

Ethics declarations

Disclosure

Michael Goggins is the Sol Goldman Professor of Pancreatic Cancer Research. A Fujimoto Medical System Scholarship to YA and the International Research Fund for Subsidy of Kyushu University School of Medicine Alumni.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ando, Y., Dbouk, M., Blackford, A.L. et al. ASO Visual Abstract: Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery. Ann Surg Oncol 31, 2979–2980 (2024). https://doi.org/10.1245/s10434-024-15023-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-024-15023-3

Navigation